Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D BAIRD

Showing results (611-620 of 629) with videos related to

Pageof 63
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer PatientsRichard D Baird, Annelot G J van Rossum, Mafalda Oliveira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid TumorsAtish D Choudhury, Celestia S Higano, Johann S de Bono, et al.
Nature Cancer|February 28, 2022
The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncologyDavid Tamborero, Rodrigo Dienstmann, Maan Haj Rachid, et al.
The Journal of Trauma and Acute Care Surgery|May 29, 2023
The last days: The medical response of United States and allied military teams during the Afghanistan ExodusJoseph D Bozzay, Timothy P Murphy, Michael D Baird, et al.
Molecular Cancer|August 18, 2023
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancerAntonino Glaviano, Aaron S C Foo, Hiu Y Lam, et al.
Physical Review. E|March 18, 2023
Measuring the principal Hugoniot of inertial-confinement-fusion-relevant TMPTA plastic foamsR W Paddock, M W von der Leyen, R Aboushelbaya, et al.
Nature Communications|December 14, 2020
Automation and control of laser wakefield accelerators using Bayesian optimizationR J Shalloo, S J D Dann, J-N Gruse, et al.
Free Radical Biology & Medicine|February 22, 2005
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?M B Kadiiska, B C Gladen, D D Baird, et al.
Science Translational Medicine|November 9, 2018
Enhanced detection of circulating tumor DNA by fragment size analysisFlorent Mouliere, Dineika Chandrananda, Anna M Piskorz, et al.
Cancer Discovery|June 13, 2024
Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care GloballyJavier Carmona, Elena Chavarria, Kate Donoghue, et al.
Pageof 63

Showing results (611-620 of 629) with videos related to

Sort By:
Pageof 63
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer PatientsRichard D Baird, Annelot G J van Rossum, Mafalda Oliveira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid TumorsAtish D Choudhury, Celestia S Higano, Johann S de Bono, et al.
Nature Cancer|February 28, 2022
The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncologyDavid Tamborero, Rodrigo Dienstmann, Maan Haj Rachid, et al.
The Journal of Trauma and Acute Care Surgery|May 29, 2023
The last days: The medical response of United States and allied military teams during the Afghanistan ExodusJoseph D Bozzay, Timothy P Murphy, Michael D Baird, et al.
Molecular Cancer|August 18, 2023
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancerAntonino Glaviano, Aaron S C Foo, Hiu Y Lam, et al.
Physical Review. E|March 18, 2023
Measuring the principal Hugoniot of inertial-confinement-fusion-relevant TMPTA plastic foamsR W Paddock, M W von der Leyen, R Aboushelbaya, et al.
Nature Communications|December 14, 2020
Automation and control of laser wakefield accelerators using Bayesian optimizationR J Shalloo, S J D Dann, J-N Gruse, et al.
Free Radical Biology & Medicine|February 22, 2005
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?M B Kadiiska, B C Gladen, D D Baird, et al.
Science Translational Medicine|November 9, 2018
Enhanced detection of circulating tumor DNA by fragment size analysisFlorent Mouliere, Dineika Chandrananda, Anna M Piskorz, et al.
Cancer Discovery|June 13, 2024
Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care GloballyJavier Carmona, Elena Chavarria, Kate Donoghue, et al.
Pageof 63